返回 Agenda
Session 5, Part 1: Tech Innovation for Life Sciences
Session Chair(s)
Scott Askin, MSC
Global Program Regulatory Director
Novartis Pharma AG, Switzerland
Michael Forstner, PHD, MPH, MSC
Managing Director, Head of Pharmacoepidemiology Practice
Mesa Laubela-Consulting, Switzerland
Session 5, Part 1: Tech Innovation for Life Sciences
Speaker(s)
AI Application for Early Diagnosis in Rare Disease
Greg Davis
Analytics4Life (A4L), United States
COO